German mid-market domiciliary care provider SunaCare claims it will double in size by next year. Is this viable in the midst of a staffing crisis? HBI talks to the company's senior strategist to find out more.
We talk to consultancy Alvarez & Marsal's (A&M) recently-appointed head of European Healthcare & Life Sciences industry practice, medtech specialist Ray Berglund, about the sector's move into healthcare services.
HBI talks to Tim Clover, CEO of ophthalmology medtech supplier Rayner and former CEO of ophthalmology operator Optegra about his take on the market, challenges and opportunities in the future, and plans for the company going forward, including coming to market in the next two years - or sooner.
Global dialysis supplier-provider B. Braun's Ghanian distributor, Engisys, has launched a private dialysis clinic in the capital Accra. We talk to its managing director about the local market.
We talk to the CFO of Turkey's largest private hospital group by beds, MLP Care, 18 months on from its Istanbul listing. Burcu Ozturk discusses the Turkish economy, MLP's postponed M&A plans and growing its private and international revenues amidst a stagnant statutory insurance segment.
Attendo admitted it is "facing a challenging period" as it announced a Q2 loss, and has had issues with its Finnish operations - predominantly due to dropping occupancy and staff shortages.
Fresenius Helios has formed a new telemedicine joint-venture that will create an occupational healthcare tool to increase patient flow in Germany. The company exclusively tells HBI it wants to roll out to Spain.
Brazil's biggest lab company Dasa has said it expects its genetic testing subsidiary to be worth more than its core routine testing business within ten years as it opens LATAM's "largest" sequencing facility.
Advent International, the big-spending PE firm which has just bought franchise-focussed Spanish dental chain Vitaldent, is planning to put millions into the business with a view to floating, according to local reports. We speak to a well-placed operator source who is surprised by the speed with which Advent seems willing to splash the cash for its latest acquisition.
After overseeing a four-fold rise in revenue, a change in culture and a move to digitalisation, Yrjö Närhinen, 49, the CEO of Terveystalo, the listed Finnish outpatient group, has decided to step down after an 8-year stint at the helm. We talk to him about the future. It is a little known fact that compared to the size of the country, Terveystalo is the largest healthcare group in Europe, employing one in 400 of the working population.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
